Help Moms With Psoriasis

MotherToBaby is currently enrolling pregnant women in an observational study to understand how psoriasis and its treatment may affect pregnancy. All studies are conducted through phone interviews—no changes to your normal routine or travel required. If you’ve taken Tremfya^® (guselkumab), Bimzelx^® (bimekizumab-bkzx), or Ilumya^® (tildrakizumab-asmn) during pregnancy, you may qualify for this important study.‎ 

“There is a huge need to generate more information for all of the drugs that pregnant women need to take.”

— Christina Chambers, PhD, MPH, MotherToBaby Pregnancy Studies

Make an impact on psoriasis research by enrolling into our pregnancy study!